Introduction: Thalassemia
disorder is a genetic disease that causes the blood to have less hemoglobin
than normal, the main requirement to control thalassemia’s propagation is to
educate the entire society. Methodology: A descriptive survey was taken
to evaluate the awareness of thalassemia among Saudi Arabia’s society, with a
sample size of 384. Results: The results were written in frequencies,
and it shows that most of the participants were unaware and lacking information
on thalassemia syndrome. Discussion: The results of this study provide
valuable insights into the awareness of thalassemia in Saudi Arabia and
highlight the need to raise awareness of this disease. Conclusion: This
study is not comprehensive because the survey was not disrupted evenly, but it
can give us an overview of the awareness of thalassemia in Saudi Arabia, and it
shows that most of the participants were unaware and lacked information on
thalassemia.
References
[1]
Faggiano, S., Ronda, L., Bruno, S., Abbruzzetti, S., Viappiani, C., Bettati, S. and Mozzarelli, A. (2022) From Hemoglobin Allostery to Hemoglobin-Based Oxygen Carriers. Molecular Aspects of Medicine, 84, 101050.
[2]
Hossain, M.S., Hasan, M.M., Raheem, E., Islam, M.S., Al Mosabbir, A., Petrou, M., et al. (2020). Lack of Knowledge and Misperceptions about Thalassaemia among College Students in Bangladesh: A Cross-Sectional Baseline Study. Orphanet Journal of Rare Diseases, 15, 1-10.
[3]
Musallam, K.M., Rivella, S., Vichinsky, E. and Rachmilewitz, E.A. (2013) Non-Transfusion-Dependent Thalassemias. Haematologica, 98, 833.
[4]
Badagabettu, S., Archana, M.V. and Jomon, C.U. (2022) Awareness on Thalassemia and Opinion of Carrier Screening among Young Women from Selected Undergraduate Colleges of Udupi District. Clinical Epidemiology and Global Health, 14, 100978.
[5]
Mahmoud, R.H.E. (2022) Identification and Molecular Characterization of the Most Common Types of Beta Thalassemia Mutations in Sudanese Patients. Doctoral Dissertation, University of Gezira, Wad Madani.
[6]
Babu, T. and Panachiyil, G.M. (2022) An Evidence-Based Approach to Treatment with Iron Chelators in Transfusion-Dependent Thalassemia Patients: Present Trends and Future Scenario. Frontiers in Clinical Drug Research-Hematology, 5, 50.
[7]
Coughlan, M., Cronin, P. and Ryan, F. (2009) Survey Research: Process and Limitations. International Journal of Therapy and Rehabilitation, 16, 9-15.
[8]
Aguilar Martinez, P., Angastiniotis, M., Eleftheriou, A., Gulbis, B., Mañú Pereira Mdel, M., Petrova-Benedict, R. and Corrons, J.L. (2014) Haemoglobinopathies in Europe: Health & Migration Policy Perspectives. Orphanet Journal of Rare Diseases, 9, 97.
